RE: CymatCredibility is most certainly an issue, and it will not entirely abate even with contracts at hand. The eventual P/E or what ever metric is used for valuation will be held back because of this. So what is being done to improve credibility? Not much of anything it seems. I am not seeing any spade work on the Investor Relation side. Yet, as was pointed out previously on this board, there are fees being paid for Investor Relations. Where is the value for this compensation?
The fact that almost 1% of the outstanding stock (fully diluted) has traded in the past two sessions, and the share price has not moved demonstrates the credibility problem. Those tendering shares for sale do not include shares from the recent private placement; they have a four month freeze. So it appears that it is other shareholders who have sold, even if the face of this good news and other excellent management results. Our board of directors have not risen to the occasion on this matter and until they do, shares will not enjoy full valuation. Pity.